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Abstract
Rare diseases affect a relatively small number of people, which limits investment in
research for treatments and cures. Developing an efficient method for rare disease
detection is a crucial first step towards subsequent clinical research. In this paper,
we present a semi-supervised learning framework for rare disease detection using
generative adversarial networks. Our method takes advantage of the large amount
of unlabeled data for disease detection and achieves the best results in terms of
precision-recall score compared to baseline techniques.
1 Introduction
A rare disease has a very low prevalence rate that affects only a small percentage of the population
[1]. Finding patients with undiagnosed rare diseases is like looking for a needle in a haystack.
Therefore, it is essential to develop efficient methods to help with detection and diagnosis in order
to raise disease awareness and to provide early disease intervention [2]. On the other hand, interest
in machine learning for healthcare has grown immensely during last several years [3, 4, 5]. Several
machine learning methods, such as Recurrent Network [6, 7], FHIR-formatted representation [8], etc.
have been proposed to predict patient-level disease. For more comprehensive overview of machine
learning application on healthcare, we refer readers to [3, 4, 5].
Recently, generative adversarial networks (GANs) [9], were demonstrated in a semi-supervised
learning (SSL) framework [10, 11], where typically a small amount of labeled data with a large
amount of unlabeled data are present. A GAN sets up two competing neural network models: a
discriminator D and a generator G. The task of D is to classify an input as either the output from
the generator (“fake” data), or actual samples from the underlying data “manifold” (“real” data) and
the class in which the samples belong. The goal of G is to produce outputs that are classified by the
discriminator as “real”, namely as coming from the underlying data “manifold”. By taking advantage
of the unlabeled data to estimate the shape of the data “manifold” and generating compliment “fake”
data to force the decision boundary to be outside of the data “manifold”, GANs demonstrate superior
performance in SSL [11, 12].
The rare disease detection problem is a good fit for SSL, where we usually have limited labeled
data that are available and aim to leverage the large amount of unlabeled data to find potential
undiagnosed patients. In this work, we follow the spirit of [10, 11], and propose a novel framework
for semi-supervised rare disease detection using a GAN. The key contributions of this paper are: 1)
we applied the SSL method to the rare disease detection problem using a GAN and achieved better
results than a baseline model; 2) we carefully designed a loss function that helped G to generate
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complement samples of the underlying data distribution; and 3) we did an extensive ablation study on
how the SSL method could help with rare disease detection and how each penalty term in the loss
function would affect model performance.
2 Methods
2.1 Data and pre-processing
We extract data from IQVIA longitudinal prescription (Rx) and medical claims (Dx) database,
including hundreds of millions patients’ clinical records. To limit scope, we focus on only one
particular rare disease, an inherited blood disorder caused by a genetic defect. It is estimated to affect
about 1 in 20,000 people according to Genetic Home Reference (GHR) from NIH.
For model development, we pulled the diagnoses, procedures, and prescriptions at transaction level
from January 1, 2010 to July 31, 2017. After applying eligibility rules, we keep only the patients
with complete Rx/Dx information for our study. We label a patient with the rare disease condition as
“positive patients”, and without the rare disease as “negative patients”. From the extracted data, we
positively identified 5,923 true rare disease patients with valid records such as gender, age and 265
disease-relevant symptoms that were pre-selected by physicians. To boost the positive signal and
model development, we constructed a training dataset by matching each positive patient with three
randomly selected negative patients. The final training data contains 5,923 positive patients, 17,769
negative patients, and 1,166,831 unlabeled patients. The testing dataset contains 1,771,227 patients
with 23,246 positive patients. The positive ratio in the testing data is about 0.013. Note that unlike
the general literature of the similar problem in computer vision [10, 11, 12], the unlabeld data in our
case doesn’t have any actual labels.
For each of the complete set of symptoms across all patient records, we calculated the time difference
between the first record date and the last record date of that symptom for each patient. Note that
if a patient is positive, only records before diagnosis are utilized to avoid information leakage. For
patients who did not have the symptom, we used the value from the patient with the maximum time
difference who had the symptom. The count and frequency for each symptom were also added as
input features. Zeros were used to fill missing values for count and frequency as these patients never
experienced certain symptoms. Time difference, count, and frequency for the 265 symptoms along
with patient age and patient gender provided us with 797 features in total for each patient. Finally, for
better training performances with GANs architecture, we linearly normalized each feature between -1
and 1, which removed potentially erroneous values and extreme outliers.
2.2 GAN model architecture
We are given a labeled dataset, L = {(x, y)}, where y ∈ {0, 1} denotes if the patient x has the
rare disease (y = 1) or not (y = 0), and an unlabeled dataset U that only has the patients’ features
x but without label y. For rare disease detection, we want a simple classification model (e.g. the
discriminator in GAN in our case) to take in x as input and output a two-dimensional vector of
logits {l0, l1}, that can be turned into class probabilities by softmax: pD(y = 1|x) = exp(l1)exp(l0)+exp(l1)
indicates the probability that the patient has the rare disease, and pD(y = 0|x) = 1−pmodel(y = 1|x)
indicates that the patient does not. For this, we follow [10, 11] to add samples from the unlabeled
dataset U and the GAN’s generator to our dataset. The unlabeled data are treated as “real data”, while
the generated data are labeled as a third “generated” class. We use l2 and pD(y = 2|x) to denote the
output logit and probability of the “generated” class for an input feature x. Note that by subtracting a
general function f(x) from the output logits, the softmax probability does not change. Thus we can
still formulate our discriminator in a binary fashion.
In our experiments, both the generator (G) and the discriminator (D) have five hidden layers. We use
weight normalization [13] and spatial drop out [14] in both G and D. We add Gaussian noise [15] to
the output of each layer of D. A Tanh layer is added to the end of G that maps the output to the range
between -1 and 1.
2
2.3 Objective functions
The objective of our model is to detect the presence of the rare disease given a patient’s input
features x. For the discriminator, the loss consists of three different parts as discussed in [10]:LD =
LL + LU + LG, where
LL = − E
x,y∼L
log pD(y|x, y ≤ 1)
LU = − E
x∼U
log pD(y ≤ 1|x)
LG = − E
x∼G
log pD(y = 2|x)
(1)
LL is the ordinary cross-entropy loss that tries to minimize misclassification among the labeled data;
LU tries to maximize the log probability that indicates the unlabeled data is real data apart from those
generated by the generator; and LG tries to maximize the log probability to map the generated data
to the “generated” class. Note that we can fix the logit l2(x) = 0 ∀x for the generated class and
the output of the softmax remains the same. We also add an entropy loss for the discriminator as
suggested by [11], Lent = Ex∼U
∑1
i=0 pD(i|x) log pD(i|x). However, empirically we found that it
hurts the performance, which will be discussed in Section 4.
For the generator, we use a feature map loss Lfm = ‖Ex∼G f(x)− Ex∼U f(x)‖2. As suggested by
[10] and [11], feature matching loss can help generate samples outside of the true data manifold due
to its weak power in distribution matching. This property helps with the semi-supervised problem.
Additionally, we also add a pull-away term
Lpt = E
x∼G
[
∑
j 6=i
(
f(xi)
T f(xj)
‖xi‖ ‖xj‖ )
2] + E
xi∼G,xj∼L
[
∑
j,i
(
f(xi)
T f(xj)
‖xi‖ ‖xj‖ )
2]. (2)
The first term on the right hand side inspired by [11] tries to orthogonalize the features in each
mini-batch by minimizing the squared cosine similarity. Hence, it can help to increase the diversity
of generated samples and avoid mode collapse. The second term tires to pull away the generated
data distribution from the true data distribution, thus the generator can generate more samples
outside of the labeled data manifold. As suggested by [11], samples from the low-density feature
space could help with semi-supervised learning in GANs. Thus our generator loss finally becomes
LG = Lfm + Lpt.
2.4 Evaluation of GAN outputs
As the testing data are highly imbalanced (only 23,246 out of 1,771,227 samples are positive),
prediction accuracy and ROC curve (receiver operating characteristic curve) fail to provide good
measurements for the model performance. We thus use precision-recall curves and the area under
the curve (PR-AUC) as an evaluation of model performance. The PR-AUC score is measured by
a Riemann summation method that applies the trapezoidal rule. The detailed explanation of this
method can be found in [16].
3 Results
3.1 Main Results
We compare the results of our best model with three different classification methods: logistic
regression (LR), neural network (NN(D)2), and random forest (RF). Our proposed GAN model
achieved the best result, 34.18%, in terms of the PR-AUC score. LR and NN(D) achieves relatively
similar results, around 29% in PR-AUC. While RF gives the poorest result, of only 10.51% PR-AUC.
The PR curves are shown in Fig.1.
2NN(D) denotes that the neural network has the same architecture as in our discriminator D.
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Figure 1: PR and AUC
scores for the proposed
GAN model and other base-
line models. Our pro-
posed GAN model achieves
the best result, 34.18% in
PR-AUC. While logistic re-
gression (LR), neural net-
work (NN(D)), random for-
est (RF), achieve 29.04%,
28.95%, and 10.51% PR-
AUC, respectively.
3.2 Ablation Study
We report the results of the ablation study in Table 1. NN(D) can be understood as the discriminator
alone in the GAN model. The original GAN model is the GAN model without SSL branch [9], while
SSL GAN stands for the semi-supervised GAN [10, 11]. FM is the feature matching. PT is the pull
away term in Eq.2. Ent refers to the conditional entropy term introduced by [11]. Further discussion
on the effects of components in our model can be found in Section 4. Note that the ablation study
may sometimes be sensitive to the labeled/unlabeled split. However, we don’t have any labeled
information about the unlabeled data in the current scenario, therefore we will leave the related study
in the future work.
Setting PR AUC Score Setting PR AUC Score
NN(D) 28.95% SSL GAN FM + PT 34.18%
Original GAN 29.08% SSL GAN FM + Ent 30.20%
SSL GAN FM 32.06% SSL GAN FM + PT + Ent 30.33%
Table 1: Ablation study.
4 Discussion
The results in Fig.1 show the power of unlabeled data. Our proposed model provides a way to
leverage the large amount of unlabeled data, improving performance by roughly 5% in terms of
PR-AUC. The competing methods can only take advantage of the labeled data, which results in a
worse performance. Note that in the evaluation, we are identifying 23,246 positive samples out of
1,771,227 (ratio = 1.3%) for a PR-AUC of 34.18%, which is a significant improvement given the
severe imbalance of the data.
The results of the ablation study in Table 1 provide us with two insights. First, the large amount
of unlabeled data is again key for good performance. Models without unlabeled data (NN(D) and
Original GAN) achieve relatively low PR-AUC scores. Second, designing a good loss function is
essential to achieve the best result. FM plus PT as discussed in Section 2.3 forms the best design in our
case. FM helps the generator generate samples close to the data manifold, and PT helps the generator
generate more samples from the low-density boundary and increase the diversity of the generated
samples. We also add the Ent term in our model. However, empirically we found that it hurts model
performance. A possible explanation by [11] relates to the classic exploitation-exploration trade-off.
Further theoretical explanations and experiments, beyond the scope of this paper, need to be done to
provide more insights about the Ent term.
4
5 Conclusion
In this work, we present a semi-supervised learning framework for rare disease detection using
generative adversarial network. We design a loss function that helps generate samples that reside in
the complement of the real data “manifold”, and achieves 34.18% in PR-AUC, around 5% higher
compared to our baseline model. Extensive ablation study shows that generated data and unlabeled
data help with the model performance by forcing the logits of the true classes to be low outside of the
data “manifold” and providing the model with more hints on real data distribution. Our proposed
method has potential for future uses in detecting rare diseases, as well as other areas, such as medical
image analysis, in which scenario labeling data is time-consuming and expensive.
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